→
MetLife Inc currently trades at $79.78, with a market cap of $51.33B, reflecting a P/E ratio of 14.18. Despite a revenue growth of 5.29% year-over-year, the EPS has declined by 15.24%, indicating underlying challenges. Analyst sentiment is mixed with 5 Strong Buy ratings, but the earnings have been inconsistent, leading to a cautious outlook.
Hold MetLife stock for now as the mixed earnings and revenue growth present a wait-and-see scenario.
If MetLife can improve its EPS growth, which currently stands at -15.24%, it may regain investor confidence and move closer to its 52-week high of $83.85. Additionally, the solid revenue growth of 5.29% suggests potential for future profitability if managed well.
The declining EPS growth of -15.24% signals potential long-term challenges, and the low current ratio of 0.04 raises concerns about liquidity. Furthermore, the inconsistent earnings performance, with a recent miss in Q2 2025, may deter investors seeking stability.
Want AI analysis of your entire portfolio?
Helm Terminal connects to your brokerage, analyzes every holding, and delivers actionable intelligence weekly.
Get started freeHelm provides financial data for informational purposes only. This is not financial, investment, or tax advice. Consult a qualified professional before making financial decisions.
Helm's AI rates MET as Neutral. Hold MetLife stock for now as the mixed earnings and revenue growth present a wait-and-see scenario.
The declining EPS growth of -15.24% signals potential long-term challenges, and the low current ratio of 0.04 raises concerns about liquidity. Furthermore, the inconsistent earnings performance, with a recent miss in Q2 2025, may deter investors seeking stability.
If MetLife can improve its EPS growth, which currently stands at -15.24%, it may regain investor confidence and move closer to its 52-week high of $83.85. Additionally, the solid revenue growth of 5.29% suggests potential for future profitability if managed well.
MetLife Inc currently trades at $79.78, with a market cap of $51.33B, reflecting a P/E ratio of 14.18. Despite a revenue growth of 5.29% year-over-year, the EPS has declined by 15.24%, indicating underlying challenges. Analyst sentiment is mixed with 5 Strong Buy ratings, but the earnings have been inconsistent, leading to a cautious outlook.
MetLife Inc currently trades at $79.78, with a market cap of $51.33B, reflecting a P/E ratio of 14.18. Despite a revenue growth of 5.29% year-over-year, the EPS has declined by 15.24%, indicating underlying challenges. Analyst sentiment is mixed with 5 Strong Buy ratings, but the earnings have been inconsistent, leading to a cautious outlook. Our overall verdict is Neutral.
Helm Terminal offers free AI-powered stock analysis for MET at helmterminal.dev/analyze/MET, updated continuously during US market hours. No signup required.
Helm's analysis is generated by an AI model from live market data. It identifies risk signals, opportunities, and key metrics based on current fundamentals, recent price action, and analyst consensus. It does not execute trades, issue certified investment advice, or predict future prices.
Not financial advice. Informational use only. AI-generated content may contain errors. Consult a licensed financial advisor before making investment decisions. Helm Terminal is not registered as an investment advisor.